Global Ophthalmic Perfluorocarbon Tamponade Gas Market Growth 2025-2031
Description
The global Ophthalmic Perfluorocarbon Tamponade Gas market size is predicted to grow from US$ 84.9 million in 2025 to US$ 106 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Medical perfluoropropane gas (C3F8) is a colorless, odorless, non-toxic inert gas, chemically stable, insoluble in water, belongs to Class III medical devices, product specifications are usually 15ml. It is mainly used in vitreo-retinal detachment surgery, as a filling gas material in the eye, by absorbing nitrogen and oxygen in the surrounding tissue and expanding, creating a supporting effect on the retina, promoting its reduction and healing. The gas plays an important role in eye surgery, which can improve the surgical cure rate, reduce surgical risks and complications, simplify the surgical process, and reduce the workload of doctors.
United States market for Ophthalmic Perfluorocarbon Tamponade Gas is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Ophthalmic Perfluorocarbon Tamponade Gas is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Ophthalmic Perfluorocarbon Tamponade Gas is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Ophthalmic Perfluorocarbon Tamponade Gas players cover Alcon, Alchimia, Fluoron GmbH, Carl Zeiss Meditec AG, BVI Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Ophthalmic Perfluorocarbon Tamponade Gas Industry Forecast” looks at past sales and reviews total world Ophthalmic Perfluorocarbon Tamponade Gas sales in 2024, providing a comprehensive analysis by region and market sector of projected Ophthalmic Perfluorocarbon Tamponade Gas sales for 2025 through 2031. With Ophthalmic Perfluorocarbon Tamponade Gas sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Perfluorocarbon Tamponade Gas industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Perfluorocarbon Tamponade Gas landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Perfluorocarbon Tamponade Gas portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ophthalmic Perfluorocarbon Tamponade Gas market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Perfluorocarbon Tamponade Gas and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Perfluorocarbon Tamponade Gas.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Perfluorocarbon Tamponade Gas market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
15mL
75mL
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alcon
Alchimia
Fluoron GmbH
Carl Zeiss Meditec AG
BVI Medical
Ophthafutur
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ophthalmic Perfluorocarbon Tamponade Gas market?
What factors are driving Ophthalmic Perfluorocarbon Tamponade Gas market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Perfluorocarbon Tamponade Gas market opportunities vary by end market size?
How does Ophthalmic Perfluorocarbon Tamponade Gas break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Medical perfluoropropane gas (C3F8) is a colorless, odorless, non-toxic inert gas, chemically stable, insoluble in water, belongs to Class III medical devices, product specifications are usually 15ml. It is mainly used in vitreo-retinal detachment surgery, as a filling gas material in the eye, by absorbing nitrogen and oxygen in the surrounding tissue and expanding, creating a supporting effect on the retina, promoting its reduction and healing. The gas plays an important role in eye surgery, which can improve the surgical cure rate, reduce surgical risks and complications, simplify the surgical process, and reduce the workload of doctors.
United States market for Ophthalmic Perfluorocarbon Tamponade Gas is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Ophthalmic Perfluorocarbon Tamponade Gas is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Ophthalmic Perfluorocarbon Tamponade Gas is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Ophthalmic Perfluorocarbon Tamponade Gas players cover Alcon, Alchimia, Fluoron GmbH, Carl Zeiss Meditec AG, BVI Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Ophthalmic Perfluorocarbon Tamponade Gas Industry Forecast” looks at past sales and reviews total world Ophthalmic Perfluorocarbon Tamponade Gas sales in 2024, providing a comprehensive analysis by region and market sector of projected Ophthalmic Perfluorocarbon Tamponade Gas sales for 2025 through 2031. With Ophthalmic Perfluorocarbon Tamponade Gas sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Perfluorocarbon Tamponade Gas industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Perfluorocarbon Tamponade Gas landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmic Perfluorocarbon Tamponade Gas portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ophthalmic Perfluorocarbon Tamponade Gas market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Perfluorocarbon Tamponade Gas and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Perfluorocarbon Tamponade Gas.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Perfluorocarbon Tamponade Gas market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
15mL
75mL
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alcon
Alchimia
Fluoron GmbH
Carl Zeiss Meditec AG
BVI Medical
Ophthafutur
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ophthalmic Perfluorocarbon Tamponade Gas market?
What factors are driving Ophthalmic Perfluorocarbon Tamponade Gas market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ophthalmic Perfluorocarbon Tamponade Gas market opportunities vary by end market size?
How does Ophthalmic Perfluorocarbon Tamponade Gas break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
86 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Ophthalmic Perfluorocarbon Tamponade Gas by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Ophthalmic Perfluorocarbon Tamponade Gas by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
